Shares of Paras Healthcare, a prominent clinical specialty-led hospital platform, commenced trading on Indian stock exchanges with a strong performance on Wednesday, October 27. The healthcare provider's stock listed at ₹720 apiece on both the BSE and NSE, marking a 3.90% premium above its issue price of ₹693 per share.
This positive debut surpassed initial grey market premium (GMP) forecasts, which had suggested a more modest or flat listing. Investors who applied for the IPO saw an immediate gain, with a profit of ₹567 per lot consisting of 189 equity shares.
IPO Details and Subscription Performance
The initial public offering (IPO) for Paras Healthcare was open for subscription between October 21 and October 23, with shares offered in a price band of ₹660 to ₹693. The company successfully raised a total of ₹1,450 crore through the offering. This amount included a fresh issuance of shares worth ₹500 crore and an offer-for-sale (OFS) component of up to 1.37 crore equity shares, valued at ₹950 crore.
The IPO witnessed an overall subscription of 2.34 times, attracting bids exceeding ₹1,860 crore from nearly 1.5 lakh applications. Qualified Institutional Bidders (QIBs) showed significant interest, subscribing to their portion 3.25 times. Retail investors also participated actively, with their allocated quota being booked 2.10 times, while the Non-Institutional Investors (NIIs) segment saw a 69% subscription rate.
About Paras Healthcare
Incorporated in 1987, Paras Healthcare is a Gurugram-based entity that has grown to become a leading provider of tertiary and quaternary healthcare services across North India, Bihar, and Jharkhand. Operating under the 'Paras Health' brand, the company manages eight hospitals with a combined bed capacity of 2,211. These facilities are strategically located in key cities such as Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi, and Srinagar, offering a wide range of specialized medical services.